LSV Asset Management
PBYI icon

LSV Asset Management’s Puma Biotechnology PBYI Stock Holding History

LSV Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.3M Buy
1,941,101
+323,120
+20% +$2.84M 0.04% 342
2026
Q2 		$13.1M Buy
1,617,981
+435,113
+37% +$3.19M 0.02% 399
2026
Q1 		$7.56M Buy
1,182,868
+778,066
+192% +$5.02M 0.02% 425
2025
Q4 		$2.41M Sell
404,802
-155,119
-28% -$824K 0.01% 564
2025
Q3 		$2.97M Buy
559,921
+24,181
+5% +$103K 0.01% 532
2025
Q2 		$1.84M Buy
535,740
+482,340
+903% +$1.54M ﹤0.01% 563
2025
Q1 		$158K Hold
53,400
– – ﹤0.01% 762
2024
Q4 		$163K Buy
53,400
+23,000
+76% +$66.9K ﹤0.01% 768
2024
Q3 		$78K Hold
30,400
– – ﹤0.01% 804
2024
Q2 		$99K Hold
30,400
– – ﹤0.01% 823
2024
Q1 		$161K Sell
30,400
-56,251
-65% -$303K ﹤0.01% 810
2023
Q4 		$375K Hold
86,651
– – ﹤0.01% 761
2023
Q3 		$228K Sell
86,651
-107,900
-55% -$367K ﹤0.01% 792
2023
Q2 		$687K Hold
194,551
– – ﹤0.01% 729
2023
Q1 		$601K Sell
194,551
-6,600
-3% -$24.9K ﹤0.01% 706
2022
Q4 		$851K Buy
201,151
+19,052
+10% +$65.7K ﹤0.01% 668
2022
Q3 		$432K Buy
+182,099
New +$532K ﹤0.01% 730

Other funds holding PBYI

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ritholtz Wealth Management
Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

LSV Asset Management's PBYI Position: Q3 2026 in Review

LSV Asset Management increased its Puma Biotechnology (PBYI) stake by 20% in Q3 2026, buying an estimated $2.84M and bringing the position to 1,941,101 shares worth $19.3M. The position accounts for 0.04% of the portfolio, ranked #342.

LSV Asset Management first reported a position in PBYI in Q3 2022 and has held it in 17 quarters since. 77 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • LSV Asset Management held 1,941,101 shares of Puma Biotechnology worth $19.3M as of Q3 2026.
  • LSV Asset Management bought 323,120 Puma Biotechnology shares in Q3 2026, an estimated $2.84M.
  • Puma Biotechnology made up 0.04% of LSV Asset Management's portfolio in Q3 2026, its #342 holding.
  • LSV Asset Management first reported a position in Puma Biotechnology in Q3 2022 and has held it in 17 quarters since.
  • 77 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on LSV Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.